ACCESSIBILITY

24/7

Headlines

16:11

Sheryl Sandberg's harrowing documentary exposes Hamas sex crimes

17:56

Mobileye first quarter revenue falls by almost 50% as clients cut back on spending to clear excess stock

14:00

Melio names Boaz BenDavid as its first Chief Financial Officer

13:28

Check Point registers higher than expected Q1 profit helped by growth of AI-powered security platform

Buzz

Most popular

Daily

Weekly

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

Nvidia announces $700 million acquisition of Run:ai

Nvidia continues Israel shopping spree with acquisition of Deci

Sheryl Sandberg's harrowing documentary exposes Hamas sex crimes

Bezos Earth rules out $30 million investment in Israeli alternative protein center due to war

More news

Pharmaceuticals

20 stories about Pharmaceuticals

Building on Strong First Quarter, Teva Raises 2018 Outlook

03.05.18|Lilach Baumer and Dror Reich

The company reported a 10% decrease in revenues compared to 2017, largely due to North American Copaxone troubles, but beat analyst expectations

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman

Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April

מוסף 16.5 הון אנושי סול ג'יי בארר Sol J. Barer

Three Board Members to Leave Distraught Drugmaker Teva

26.04.18|Lilach Baumer and Dror Reich

Teva, one of the world's largest generic drugmakers, has faced increasing difficulties the past two years

General Electric, Roche Weigh Israel, Finland as Possible Locations for Joint Research Operation

22.04.18|Yoav Stoler

The World Economic Forum’s global competitiveness report for 2017-2018 ranked Israel third in innovation and Finland fourth

Israeli Cannabis Company Signs Deal With Unnamed Canadian Company Worth “Hundreds of Millions of Shekels”

16.04.18|CTech

Together Pharma announced the deal days before Israel’s cannabis export reform was blocked yet again by a ministerial dispute

אינטק פארמה ממנה את ד"ר ג'ון קוזריץ' לתפקיד יו"ר החברה

Intec Pharma Announces Public Offering of Ordinary Shares on Nasdaq

11.04.18|Dror Reich

The pharmaceutical company is currently listed on Nasdaq and the Tel Aviv Stock Exchange. Investment firm Oppenheimer & Co.will serve as the sole book-running manager

Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court

10.04.18|Dror Reich

Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners

With No Buyers, Teva to Close Israeli Medical Equipment Plant

09.04.18|Dror Reich

The facility in Ashdod is one of five Teva intends to sell or close in its home country

In Protest of New Bonus Plan, Teva Sued by Israeli Employees

15.03.18|Dror Reich

After announcing the cancellation of its annual bonuses for 2017 due to debt, the Israel-based drugmaker rolled out a performance-based bonus scheme for 2018 in February

Teva Increases Junk Senior Note Offering to $4.5 Billion

08.03.18|Lilach Baumer

Last week the debt-laden drugmaker announced a $3.5 billion-equivalent offering to repay its short-term $1.5 billion outstanding debt due July

Teva to Repay Due Loans with Junk Bond Private Offering

01.03.18|Lilach Baumer

The debt-laden generic drugmaker is offering around $3.5 billion in senior notes in both dollar and euro denominations

Teva Shut Down New York, Washington Offices, Says CEO

23.02.18|Dror Reich

In a meeting with investors in Israel, CEO Kåre Schultz said the Washington offices were used mainly by lobbyists, for which Teva has no further need

Teva No Longer Provides Timeline for Recovery

21.02.18|Uri Tal-Tenne

In 2017, the company said it expected moderate growth in operating profits in the U.S. in 2020

Teva Turns to Meritocracy as Part of Turnaround Plan

18.02.18|Dror Reich

A new policy the company is rolling out would see Teva employees compensated according to key performance indicators

Berkshire Hathaway Takes Position in Generic Drugmaker Teva

15.02.18|Lilach Baumer

The holding company disclosed a $358 million stake in the struggling company

Teva Gets Fresh Cash, Fresh Woes

04.02.18|Dror Reich

After the troubled drugmaker finalized two deals that will enable it to repay some of its debt, S&P placed it on CreditWatch negative on Friday

As Part of Cost-Cutting Plan, Teva Will Shut Down Twenty or More Manufacturing Sites

10.01.18|Lilach Baumer

The drugmaker will shut down 20-25 manufacturing sites in the next two years, CEO Kåre Schultz said Monday

As U.S. Domestic Issuer, Teva Reveals Top Stock Owners

03.01.18|Dror Reich

Kåre Schultz, the newly-appointed CEO of generic drugmaker Teva Pharmaceutical Industries Ltd., is one of Teva's largest shareholders, a Wednesday filing to the U.S. Securities and Exchange Commission revealed

שם: מעבדה ביוטק וושי אפטק Lab Biotech WuXi AppTec

Merck, China’s WuXi AppTec to Launch Biotech Incubator in Israel

25.12.17|Meir Orbach

Israel-born businessman Mori Arkin and life sciences-focused venture capital fund Pontifax are also partners in the venture, set to launch in 2018

Following Restructuring Announcements, Teva Reinstated as Israel’s Biggest Company

18.12.17|Lilach Baumer

Teva's stock jumped 18.7% on the New York Stock Exchange between Thursday market opening and Friday market close. Israeli Prime Minister Benjamin Netanyahu is expected to meet with CEO Kåre Schultz Tuesday

Previous Articles More Articles